Four sales representatives for Eli Lilly – Robert Rudolph, Joseph Faltaous, Steven Woodward, and Jaydeen Vincente – filed separate qui tam lawsuits against the company for illegally marketing the drug Zyprexa for uses not approved by the FDA, including the treatment of dementia in the elderly.